NCT01723241View on ClinicalTrials.gov

Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Healthy
Interventions
DRUG

XAF5, concentration A

DRUG

XAF5, concentration B

DRUG

XAF5, concentration C

DRUG

Placebo

All Listed Sponsors
lead

Topokine Therapeutics, Inc.

INDUSTRY

NCT01723241 - Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers | Biotech Hunter | Biotech Hunter